Development and Validation of an Interpretable Machine Learning Model for Predicting Early Pulmonary Metastasis Risk in Osteosarcoma
Open Access
- 20 September 2026
- journal article
- research article
- Published by Wiley in Cancer Medicine
- Vol. 15 (9) , e72209
Abstract
Introduction: Pulmonary metastasis in high‐grade conventional osteosarcoma remains a leading cause of treatment failure and mortality. Traditional monitoring methods are insufficient for early detection. This study aims to develop and validate an interpretable machine learning (ML) model using multi‐dimensional data from electronic medical records (EMR) to predict the early risk of pulmonary metastasis in high‐grade conventional osteosarcoma patients. Methods: This retrospective study included data from 522 high‐grade conventional osteosarcoma patients. After rigorous feature selection, 12 independent predictive factors were identified: prothrombin time (PT), international normalized ratio (INR), fibrinogen, globulin, prognostic nutritional index (PNI), eosinophil percentage, monocyte percentage, neutrophil percentage, monocyte count, maximum tumor diameter, gender, and amputation status. Eleven ML models were constructed and compared, with Shapley Additive Explanations (SHAP) analysis applied to enhance model interpretability and clinical transparency. Results: The gradient boosting model exhibited superior performance, achieving an area under the curve (AUC) of 0.891 in the training set and 0.742 in the independent test set. SHAP analysis revealed that tumor maximum diameter was the most influential predictor of pulmonary metastasis risk, while inflammation and coagulation‐related indicators also demonstrated significant contributions. Discussion: The gradient boosting model effectively predicts the early risk of pulmonary metastasis in high‐grade conventional osteosarcoma and provides interpretable risk factors. This model shows potential as a clinical decision support tool, facilitating personalized risk management and precision medicine, aiming to improve patient outcomes.Keywords
Funding Information
- National Natural Science Foundation of China (82302690)
This publication has 42 references indexed in Scilit:
- How does the driver respond to rear-end risk under time-varying driving styles: A temporal instability test using the model with heterogeneity in means and variancesAccident Analysis & Prevention, 2025
- Performance of an AI prediction tool for new-onset atrial fibrillation after coronary artery bypass graftingeClinicalMedicine, 2025
- Machine learning and SHAP value interpretation for predicting comorbidity of cardiovascular disease and cancer with dietary antioxidantsRedox Biology, 2024
- Development and validation of an interpretable machine learning model for predicting the risk of distant metastasis in papillary thyroid cancer: a multicenter studyeClinicalMedicine, 2024
- Prediction and validation of pathologic complete response for locally advanced rectal cancer under neoadjuvant chemoradiotherapy based on a novel predictor using interpretable machine learningEuropean Journal of Surgical Oncology, 2024
- Estimates and Projections of the Global Economic Cost of 29 Cancers in 204 Countries and Territories From 2020 to 2050JAMA Oncology, 2023
- Disparities and Trends in Genitourinary Cancer Incidence and Mortality in the USAEuropean Urology, 2022
- Metastatic osteosarcoma involving the skin: A systematic review of patient demographics, clinical characteristics, and treatment outcomesJournal of the American Academy of Dermatology, 2022
- Prediction of lung cancer risk in Chinese population with genetic‐environment factor using extreme gradient boostingCancer Medicine, 2022
- Immunotherapy for osteosarcoma: Fundamental mechanism, rationale, and recent breakthroughsCancer Letters, 2021